LINC00511

ncRNA information

ncRNA name

LINC00511

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Cervical Cancer

Cancer site

Cervix Uteri

Treatment information

Treatment type

Chemotherapy

Drug

Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

84

Male patients

Not available

Female patients

Not available

Age range and number

41(<45)+43(>=45)

Research information

PMID

Description

Silencing of LINC00511 could inhibit CC cell resistance to PTX, cell proliferation, migration and invasion, and promote cell apoptosis in CC.

Tissue resource

gastric cancer tissues than adjacent normal tissues

gastric cancer cell lines HeLa

Experiment

qRT-PCR,Western blot


Institute

Linyi Cancer Hospital

the Shandong Laboratory Animal Center

Country

China

Continent

Asia